| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Syed Kashif Zaidi | Q124988370 |
| Shams Tabrez | Q38323793 | ||
| Mohammad Amjad Kamal | Q38323812 | ||
| P2093 | author name string | Ghazi A Damanhouri | |
| Mohd Shahnawaz Khan | |||
| Shazi Shakil | |||
| Nasimudeen R Jabir | |||
| C K Firoz | |||
| Maged Mahmoud | |||
| P2860 | cites work | Pergolide and cabergoline increased risk for valvular heart disease in Parkinson disease | Q80254216 |
| Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey | Q80822259 | ||
| 2013 Alzheimer's disease facts and figures | Q86421768 | ||
| Parkinson's disease: from monogenic forms to genetic susceptibility factors | Q22242870 | ||
| Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy | Q24300975 | ||
| The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides | Q24338933 | ||
| Protein phosphatases and Alzheimer's disease | Q24632495 | ||
| Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease | Q24656668 | ||
| Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins | Q28168105 | ||
| Parkinson's disease | Q28264391 | ||
| PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria | Q28592217 | ||
| A synopsis on the role of tyrosine hydroxylase in Parkinson's disease | Q28830946 | ||
| Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders | Q29614754 | ||
| Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study | Q29615116 | ||
| Association between early-onset Parkinson's disease and mutations in the parkin gene | Q29615733 | ||
| Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein | Q31120123 | ||
| Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease | Q33782706 | ||
| Molecular mechanisms of neurodegeneration in Alzheimer's disease | Q33871297 | ||
| Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution | Q34225700 | ||
| 2012 Alzheimer's disease facts and figures | Q34260109 | ||
| Functional aspects of creatine kinase in brain. | Q34314804 | ||
| Neopterin measurement in clinical diagnosis | Q34419180 | ||
| Early Hippocampal Synaptic Loss Precedes Neuronal Loss and Associates with Early Behavioural Deficits in Three Distinct Strains of Prion Disease. | Q34808386 | ||
| Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease | Q34960461 | ||
| Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study | Q34983826 | ||
| Genetic and environmental factors in the cause of Parkinson's disease | Q35094884 | ||
| Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression | Q35214758 | ||
| Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin | Q35359238 | ||
| Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice. | Q35430964 | ||
| APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage | Q36226613 | ||
| Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. | Q36512147 | ||
| Cardiovascular disease and Alzheimer's disease: common links | Q36570775 | ||
| Mitochondria-targeted peptide antioxidants: novel neuroprotective agents | Q36616338 | ||
| Heart disease as a risk factor for dementia | Q36811092 | ||
| Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease | Q36931245 | ||
| Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study | Q37310717 | ||
| Oxidative stress and neurodegenerative disorders | Q37421024 | ||
| Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. | Q37554972 | ||
| Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease | Q37789909 | ||
| Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond | Q37880734 | ||
| Fyn kinase in brain diseases and cancer: the search for inhibitors | Q37886227 | ||
| Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis | Q37957562 | ||
| α-Synuclein in Parkinson's disease | Q37987146 | ||
| Targeting Parkinson's - tyrosine hydroxylase and oxidative stress as points of interventions | Q38000758 | ||
| Neurochemistry and the non-motor aspects of PD. | Q38022038 | ||
| The global prevalence of dementia: a systematic review and metaanalysis | Q38073027 | ||
| Alzheimer's and type 2 diabetes treatment via common enzyme targeting | Q38140977 | ||
| Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies | Q38483442 | ||
| Loss of LRPPRC causes ATP synthase deficiency | Q38806341 | ||
| Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. | Q40273125 | ||
| Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease | Q42005467 | ||
| Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease | Q43693812 | ||
| The current and projected economic burden of Parkinson's disease in the United States | Q44988421 | ||
| Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia | Q46191441 | ||
| Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities | Q48501090 | ||
| Dietary studies on two rural Italian population groups of the Seven Countries Study. 2. Concurrent validation of protein, fat and carbohydrate intake. | Q54641265 | ||
| Cognitive impairment in heart failure | Q58700310 | ||
| Urinary neopterin index as a measure of rheumatoid activity | Q69601904 | ||
| Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland | Q75445666 | ||
| P433 | issue | 1 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 19-23 | |
| P577 | publication date | 2014-09-06 | |
| P1433 | published in | Saudi Journal of Biological Sciences | Q26842015 |
| P1476 | title | An overview on the correlation of neurological disorders with cardiovascular disease | |
| P478 | volume | 22 |
| Q53674344 | Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients. |
| Q40449997 | Central hemodynamics and arterial stiffness in idiopathic and multiple system atrophy. |
| Q36578455 | Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment |
| Q50595857 | Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1. |
| Q38619805 | New approach to generating insights for aging research based on literature mining and knowledge integration |
| Q36464243 | Parkinson's disease between internal medicine and neurology |
Search more.